Safeguarding / Third-Party Involvement · Intermediate · Older adults and end of life care
Medication Error in a Nursing Home
Practise this SCA case with a voice-based AI patient that responds in real time — just like the real exam.
Clinical Scenario
Ana Hopkins, a care assistant at a residential care facility, calls to report a medication administration error. Robert Henderson, 74, who has vascular dementia, type 2 diabetes, hypertension, and atrial fibrillation, was accidentally given another resident's mirtazapine 30mg approximately 90 minutes ago. His regular medications are memantine, metformin, ramipril, and edoxaban. He is currently asymptomatic with stable observations. The care home is requesting medical advice on whether Robert needs hospital assessment.
What This Case Tests
Assessing the clinical risk of an incorrect medication administration; providing proportionate medical advice (not over-escalating for a low-risk error); addressing the systems failure that allowed the error; understanding duty of candour and incident reporting requirements; supporting the care worker who made or reported the error.
Common Mistakes Trainees Make
The three most common mistakes are: sending Robert to A&E unnecessarily (a single therapeutic dose of mirtazapine in a stable patient is low risk and can be monitored in the care home), focusing only on the clinical management without addressing the systems failure (how did another resident's medication reach Robert?), and being punitive toward the care worker rather than supportive and systems-focused.
The Consultation Challenge
This is both a clinical assessment and a systems governance event. A single therapeutic dose of mirtazapine 30mg was given to the wrong patient 90 minutes ago. Your immediate task is assessing the clinical risk; your secondary task is ensuring the care home manages this properly as a patient safety incident.
Clinical assessment first. Mirtazapine 30mg is a therapeutic (not toxic) dose. It has a wide therapeutic index and is considerably safer in overdose than tricyclic antidepressants. Expected effects from a single dose include sedation and drowsiness (onset 1-2 hours, lasting 12-24 hours), possible dry mouth, and mild postural hypotension. In Robert's case, monitor for: excessive sedation (risk of aspiration if eating/drinking while drowsy), postural hypotension (risk of falls — he has dementia and may not report dizziness), and interaction with edoxaban (minimal at single dose, but monitor for bleeding signs). Overall risk: low. Hospital assessment is not required if he can be monitored in the care home.
Monitoring plan: observations every 2 hours for the next 12 hours (blood pressure, heart rate, conscious level), withhold any sedating medications due tonight, ensure someone checks on Robert if he falls asleep (aspiration risk), maintain hydration, and call back if any deterioration.
Now address the systems failure. A medication error in a care home is a patient safety incident that requires: completion of a Datix or equivalent incident report, notification of the care home manager, notification of Robert's family (duty of candour), review of the medication administration process that allowed the error, and consideration of whether CQC notification is required (for significant harm events).
Support the care worker. Ana reported the error promptly, which is the correct action. A blame culture suppresses error reporting, which is far more dangerous than the errors themselves. Acknowledge her professionalism: "You did exactly the right thing by reporting this immediately."
Time check: Spend the first 3 minutes on the clinical risk assessment and monitoring plan. By minute 5, provide the clear recommendation (monitoring in care home, no hospital transfer). Use minutes 6-9 for the systems and governance discussion. Reserve the final 3 minutes for family notification, supporting the care worker, and follow-up.
How Examiners Mark This Case
Data Gathering and Diagnosis: Examiners assess whether you gather the essential information for risk assessment: which medication was given, at what dose, how long ago, the patient's current observations and symptoms, his regular medications (interactions), and his comorbidities (dementia and AF increase vulnerability to sedation and falls). They also look for whether you ask how the error occurred — the systems question is part of the clinical picture.
Clinical Management and Medical Complexity: Examiners expect a proportionate assessment: mirtazapine 30mg as a single dose is low risk, monitoring in the care home is appropriate, and hospital transfer is not indicated. They look for a specific monitoring plan (frequency of observations, what to watch for, when to escalate), medication interaction awareness (edoxaban, existing dementia medications), and knowledge of care home governance (incident reporting, family notification, CQC consideration).
Relating to Others: Examiners assess whether you support the care worker who reported the error (positive reinforcement of reporting culture), communicate the plan clearly so care home staff can implement it, and ensure the family is informed appropriately (duty of candour). The consultation should model a systems-thinking approach to patient safety, not a blame approach.
Example Opening
Strong opening: "Thank you for reporting this straight away, Ana — that's exactly the right thing to do. Let me assess whether Robert is at any risk, and then we'll talk about the next steps. First, how is he right now? Can you check his blood pressure and tell me if he seems his normal self?"
When giving the clinical assessment: "The good news is that mirtazapine at this dose is unlikely to cause Robert any serious harm. The main thing to watch for is drowsiness — it may make him sleepy over the next few hours. I don't think he needs to go to hospital, but I do need the care home to monitor him closely. Let me give you a specific plan."
When addressing the governance: "Beyond Robert's immediate care, this needs to go through your incident reporting process. Can you make sure the care home manager is aware, and that a formal incident report is completed? Robert's family should also be informed — they have a right to know."
Avoid: "Who made this mistake? They need retraining." (Blame-focused rather than systems-focused).
How This Appears in the SCA
This case tests proportionate clinical risk assessment, care home governance knowledge, and systems-thinking about patient safety. Examiners assess whether you can manage the immediate clinical concern without over-escalating, address the root cause of the error, and demonstrate understanding of duty of candour and incident reporting.
Key Statistic
Medication errors in care homes occur in approximately 8-10% of medication rounds. The most common errors are wrong drug, wrong dose, and wrong patient. Prompt reporting and a no-blame culture are associated with significantly better patient safety outcomes than punitive approaches.
Relevant Guidelines
- NICE SC1: Managing medicines in care homes
- CQC guidance on medication management in care homes
- Duty of candour regulations (Health and Social Care Act 2008).
Frequently Asked Questions
How do I assess the risk of a wrong medication administration?
Key factors: what medication was given (therapeutic index, toxicity profile), at what dose (therapeutic versus supratherapeutic), time since administration (determines intervention window), the patient's current clinical status, their comorbidities (renal impairment, liver disease, cognitive state), and potential interactions with their regular medications. For most medications at therapeutic doses as single events, the acute risk is low. High-risk wrong-drug events involve insulin, opioids, anticoagulants, and cardiac medications.
When should a medication error in a care home prompt hospital transfer?
Transfer if: the medication has a narrow therapeutic index and the dose could cause toxicity, the patient is symptomatic, the patient's comorbidities increase vulnerability (severe renal impairment, cardiac disease), the medication requires specific monitoring or antidote not available in the care home, or the care home cannot provide adequate observation. A single therapeutic dose of mirtazapine in a stable patient with available nursing monitoring does not meet these criteria.
What is duty of candour and how does it apply to medication errors?
Duty of candour requires healthcare providers to inform patients (or their representatives) when a patient safety incident has occurred, apologise, and explain what happened and what will be done to prevent recurrence. In a care home, this means the manager must inform Robert's family about the medication error, even if no harm resulted. This is a legal requirement, not optional. Demonstrating knowledge of duty of candour shows professional awareness.
How should I approach the systems failure rather than blaming the individual?
A systems approach asks: what allowed this error to happen? Was there a process failure (two residents' medications stored together), a staffing issue (understaffed shift, inadequate supervision), a training gap, or an environmental factor? Individual blame suppresses future error reporting, which is far more dangerous than any single error. Support the reporter: "You did the right thing by telling us immediately. Now let's make sure the system is fixed so this can't happen again."
What monitoring plan should I implement for a mirtazapine administration error?
Monitor every 2 hours for 12 hours: blood pressure (lying and standing), heart rate, conscious level (is he rousable? Speaking normally?), and general wellbeing. Withhold any other sedating medications due that evening. If he becomes drowsy, ensure he is positioned safely (recovery position if deeply sedated), do not offer food or drink while sedated (aspiration risk), and ensure someone checks on him regularly overnight. Escalate if: GCS drops below 14, BP falls below 90/60, or any new symptoms develop.